Vaccines (Apr 2021)

Transcriptome of Tumor-Infiltrating T Cells in Colorectal Cancer Patients Uncovered a Unique Gene Signature in CD4<sup>+</sup> T Cells Associated with Poor Disease-Specific Survival

  • Salman M. Toor,
  • Varun Sasidharan Nair,
  • Reem Saleh,
  • Rowaida Z. Taha,
  • Khaled Murshed,
  • Mahmood Al-Dhaheri,
  • Mahwish Khawar,
  • Ayman A. Ahmed,
  • Mohamed A. Kurer,
  • Mohamed Abu Nada,
  • Eyad Elkord

DOI
https://doi.org/10.3390/vaccines9040334
Journal volume & issue
Vol. 9, no. 4
p. 334

Abstract

Read online

Colorectal cancer (CRC) is influenced by infiltration of immune cell populations in the tumor microenvironment. While elevated levels of cytotoxic T cells are associated with improved prognosis, limited studies have reported associations between CD4+ T cells and disease outcomes. We recently performed transcriptomic profiling and comparative analyses of sorted CD4+ and CD8+ tumor-infiltrating lymphocytes (TILs) from bulk tumors of CRC patients with varying disease stages. In this study, we compared the transcriptomes of CD4+ with CD8+ TILs. Functional annotation pathway analyses revealed the downregulation of inflammatory response-related genes, while T cell activation and angiogenesis-related genes were upregulated in CD4+ TILs. The top 200 deregulated genes in CD4+ TILs were aligned with the cancer genome atlas (TCGA) CRC dataset to identify a unique gene signature associated with poor prognosis. Moreover, 69 upregulated and 20 downregulated genes showed similar trends of up/downregulation in the TCGA dataset and were used to calculate “poor prognosis score” (ppScore), which was significantly associated with disease-specific survival. High ppScore patients showed lower expression of Treg-, Th1-, and Th17-related genes, and higher expression of Th2-related genes. Our data highlight the significance of T cells within the TME and identify a unique candidate prognostic gene signature for CD4+ TILs in CRC patients.

Keywords